Key result
Epigenetic modifications link environmental exposures to gene expression, highlighting novel diagnostic and therapeutic targets in CVD.
This review highlights the role of the epigenome as a mechanistic link between environmental exposures and cardiovascular disease, offering potential targets for future diagnostics and therapies.
A plethora of environmental and behavioral factors interact, resulting in changes in gene expression and providing a basis for the development and progression of cardiovascular diseases. Heterogeneity in gene expression responses among cells and individuals involves epigenetic mechanisms. Advancing technology allowing genome-scale interrogation of epigenetic marks provides a rapidly-expanding view of the complexity and diversity of the epigenome. In this review, we discuss the expanding landscape of epigenetic modifications and highlight their importance for our future understanding of disease. The epigenome provides a mechanistic link between environmental exposures and gene expression profiles ultimately leading to disease. We discuss the current evidence for transgenerational epigenetic inheritance and summarize the data linking epigenetics to cardiovascular disease. Furthermore, we review the potential targets provided by the epigenome for the development of future diagnostics, preventive strategies, and therapy for cardiovascular disease. Finally, we provide some suggestions for future directions.
No takes yet. Share an insight, caveat, or question.
Harst et al. (2017) conducted a review in Cardiovascular disease. Epigenetic modifications was evaluated. Epigenetic modifications provide a mechanistic link between environmental exposures and gene expression profiles, offering potential targets for diagnostics and therapy in cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: